Hims & Hers stock has been a mega-outperformer for investors, growing more than 600% over the past year, largely on the back of its compounded semaglutide products that mimic the effect of Ozempic and similar weight loss drugs from Big Pharma companies like Novo Nordisk and Eli Lilly.
👉 Subscribe to InvestingPro:
1. 🚨 Trade Tracker:
2.✅ Join LPP (Daily Live Trading):
3. 📸 Instagram:
4. Apparel For Entrepreneurs:
5.📊 Earn 20 FREE Stocks (WEBULL):
For those who are interested in Trading & Investing, I encourage you to join Our Free Trading Group of over 300,000
#HIMS #palantir #AINEWS #stockmarketnews
Thank you for the support, the best way to reach out to me is through our private discord chat, please DM me.
source
